Celltrion’s monoclonal antibody treatment for COVID-19 works against Delta variant: Study
Regdanvimab (CT-P59) also retained its neutralisation potency against the Lambda variant (C.37, first identified in Peru) using a…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.